On the basis of the abovementioned negative results in the normal specimens, we propose that methylation, but not necessarily hypermethylation, plays a role in the down-regulation of the p16 gene promoter at least in Iranian individuals with HCC. This evidence concerns the gene CDKN2A and hepatocellular carcinoma.